Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Ospedale San Raffaele S R L manages a company patent portfolio within the Chemistry & Materials technology area. The portfolio currently faces 2 pending office actions. These actions represent the active legal challenges the company must navigate to secure its intellectual property rights. The focus on chemistry and materials suggests that the underlying technology involves material science or chemical compositions.
The 2 pending office actions are spread across 2 distinct examiners and 2 distinct art units. This distribution shows that the company's technology is being reviewed by multiple specialized divisions within the patent office. Because there are 2 distinct examiners involved, the company must manage 2 separate lines of communication. The use of 2 distinct art units further indicates that the pending applications may cover different sub-specialties within the broader chemistry field.
MARCHESCHI, MICHAEL A is the busiest examiner for this portfolio, currently handling 1 pending office action. Given that there are 2 pending office actions in total, the workload is split between the 2 distinct examiners. Each examiner is responsible for 1 pending action. This distribution means that no 1 examiner dominates the company's current prosecution landscape, requiring the legal team to address feedback from 2 different officials.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARCHESCHI, MICHAEL A | 1 | 20.0% | +17.9% |
| BARSKY, JARED | 1 | 50.3% | +22.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042376 | DEVICE FOR BIOLOGICAL CULTURES | MARCHESCHI, MICHAEL A | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17910971 | TREATMENT OF STEM CELL DEFICIENCY | BARSKY, JARED | 20d |
| 18042376 | DEVICE FOR BIOLOGICAL CULTURES | MARCHESCHI, MICHAEL A | 21d |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18042376 | DEVICE FOR BIOLOGICAL CULTURES | MARCHESCHI, MICHAEL A | 1796 | §102§103§112 | Final Rejection | 21d | Pending | Feb 21, 2023 |
| 17910971 | TREATMENT OF STEM CELL DEFICIENCY | BARSKY, JARED | 1628 | §102§103DP | Final Rejection | 20d | Pending | Sep 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOspedale San Raffaele S R L has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Michael A Marcheschi has the most, with 1 of Ospedale San Raffaele S R L's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
